Crossmark

SALL4 mediates SHP2 inhibition in myocardial fibroblasts through the DOT1L/H3K79me2 signaling pathway to promote the progression of myocardial infarction

Crossref DOI link: https://doi.org/10.1038/s41598-024-81815-y

Published Online: 2024-12-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zong, Yanhong

Zhao, Ming

Tang, Zhipeng

Tie, Yanqing

Peng, Kenan

Tan, He
Funding

Funding for this research was provided by:

Medical Science Research Project of Hebei Province (20190017)
License Information

Text and Data Mining valid from 2024-12-28

Version of Record valid from 2024-12-28
More Information

Article History

Received: 9 May 2024

Accepted: 29 November 2024

First Online: 28 December 2024

Competing interests

: The authors declare no competing interests.

: The animal experiment was approved by the Medical Ethics Committee of Hebei Provincial People’s Hospital (2024-DW-056).

Document is current

Any future updates will be listed below